Furthermore, dynein cytoplasmic intermediate light chain 1 (DYNC1I1) had increased expression in both LNCaP and PC-3 prostate cancer cell lines (See Supplementary Table 1 for fold change and P-values). This evidence concerns the gene DYNC1I1 and prostate carcinoma.